Our study demonstrated that MUC16 up-regulation induced by gene mutations may be involved in the development and progression of lung cancer and that MUC16 may be a potential marker for diagnosis, predicting prognosis, monitoring recurrence, and guiding the treatment of NSCLC. The gene discussed is MUC16; the disease is lung carcinoma.